SABCS: Pregnancy Less Likely After Breast Cancer Diagnosis
Disease - free, overall survival better for breast cancer patients with versus without subsequent pregnancy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 14, 2020 Category: Cancer & Oncology Tags: Gynecology, Oncology, Conference News, Source Type: news
SABCS: Pregnancy Less Likely After Breast Cancer Diagnosis
MONDAY, Dec. 14, 2020 -- Pregnancy is less likely after prior breast cancer (BC) diagnosis, according to the results of a review presented at the annual San Antonio Breast Cancer Symposium, held virtually from Dec. 8 to 11.
Eva Blondeaux, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 14, 2020 Category: Pharmaceuticals Source Type: news
Pregnancy is safe for breast cancer survivors
Most breast cancer survivors who get pregnant have good outcomes and deliver...Read more on AuntMinnie.comRelated Reading:
Skipping rad therapy may not hinder breast cancer survival
Imaging detects big, rare tumor protruding from fetus's mouth
Ultrasound vs. mammo: What's best for lactating women?
CT details effect of COVID-19 on pregnant women
More pregnant women are undergoing imaging (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 10, 2020 Category: Radiology Source Type: news
Second opinion changed breast cancer treatment, preserved fertility
Everyone ’s breasts get lumpy when they’re nursing a newborn, right? That’s what Leslie McGuire, age 30, thought to herself in 2014.
“Breastfeeding wasn’t easy for me, and I had a lot of breast changes after my pregnancy, so when I felt a lump, I just assumed it must be related to that,” says t he Kansas City, Missouri, resident. But with an extensive family history of breast and ovarian cancers, McGuire was concerned when the lump didn’t disappear after she stopped nursing.
She thought… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 1, 2020 Category: Pharmaceuticals Authors: The University of Kansas Health System Source Type: news
Pregnancy Outcomes Excellent After BRCA Breast Cancer Treatment Pregnancy Outcomes Excellent After BRCA Breast Cancer Treatment
Pregnancy after treatment for breast cancer with BRCA mutations is safe, with excellent fetal outcomes and no increase in cancer recurrence, say researchers reporting a review of more than 1000 women.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 16, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Micro-CT visualizes early fetal development
Dutch researchers have released images acquired using micro-CT that depict...Read more on AuntMinnie.comRelated Reading:
Contrast MRI helps radiologists identify ectopic pregnancy
3D micro-CT primed to revamp breast cancer imaging
Micro-CT unveils curious history of ancient manikins
Micro-CT detects early tumor growth in lymph nodes
Micro-CT reveals hawk mummy is actually a human fetus (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 13, 2020 Category: Radiology Source Type: news
Pregnancy reprograms breast cells, reducing cancer risk
(Cold Spring Harbor Laboratory) Women who are pregnant before the age of 25 have a decreased risk of breast cancer throughout their lives. Searching for the mechanism behind this life-saver, CSHL researchers discovered that pregnancy reprograms the breast cells to turn off a cancer gene and turn on a gene that arrests cell growth. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 27, 2020 Category: Cancer & Oncology Source Type: news
ERLEADA ® (apalutamide) Significantly Improved Overall Survival in Patients with Non-Metastatic Castration-Resistant Prostate Cancer
RARITAN, NJ, May 13, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today results from the final analysis of the pivotal Phase 3 SPARTAN study demonstrating ERLEADA® (apalutamide) in combination with androgen deprivation therapy (ADT) significantly improved overall survival (OS), compared to ADT alone, in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who were at high risk of developing metastases.[i] Results will be presented at the American Society of Clinical Oncology (ASCO) Virtual Scientific Program (Abstract #5516) beginning May 29th. ERLEADA® in combina...
Source: Johnson and Johnson - May 14, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Rise in breast cancer fueled by more than later pregnancy, lower birth rate
Rising breast cancer rates in the U.S. during the last 40 years have long been linked with women opting to have children later in life, if at all. An analysis published Friday, however, challenges that idea. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 13, 2020 Category: Consumer Health News Source Type: news
Mother diagnosed with breast cancer during pregnancy feared she would lose her baby
Kirsty Guy, 30, from Ellesmere Port, Cheshire, assumed a lump in her right breast was a symptom of her pregnancy and claims she was reassured by her GP. (Source: the Mail online | Health)
Source: the Mail online | Health - March 2, 2020 Category: Consumer Health News Source Type: news
Janssen to Highlight Depth of Solid Tumor Portfolio at ASCO GU
RARITAN, N.J., February 3, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple data presentations from a robust solid tumor portfolio that will be featured at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15 in San Francisco. Company-sponsored data presentations will include clinical results for ERLEADA® (apalutamide) and niraparib in prostate cancer; and BALVERSA™ (erdafitinib) in bladder cancer. “We are committed to improving outcomes in patients with prostate and bladder cancer where high unmet needs continue...
Source: Johnson and Johnson - February 3, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Combining neurologic and blood pressure drugs reduces breast tumor development in mice
(Georgetown University Medical Center) Adding a medication used to treat epilepsy, bipolar disorder and migraines to a blood pressure medicine reversed some aspects of breast cancer in the offspring of mice at high risk of the disease because of the high fat diet fed to their mothers during pregnancy. Conversely, this treatment combination increased breast cancer development in the offspring whose mothers had not been fed a high fat diet during pregnancy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 30, 2019 Category: International Medicine & Public Health Source Type: news
Saving lives, improving mother's care
This report, the sixth MBRRACE-UK annual report of the Confidential Enquiry into Maternal Deaths and Morbidity, includes: surveillance data on women who died during or up to one year after pregnancy between 2015 and 2017 in the UK; Confidential Enquiries into the care of women who died between 2015 and 2017 in the UK and the Republic of Ireland from cardiovascular causes, hypertensive disorders, early pregnancy conditions and accidents; a Morbidity Confidential Enquiry into the care of women with newly diagnosed breast cancer. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 17, 2019 Category: Consumer Health News Source Type: news
Cancer patients want more info on treatment downside
One in three adults wish they had known more about side effects before beginning...Read more on AuntMinnie.comRelated Reading:
Black women still at higher risk of breast cancer death
ASTRO: Radiation can nix side effects of T-cell therapy
ASTRO: AI predicts side effects from radiation therapy
How does chemo during pregnancy affect child development?
Advanced imaging offers insight into targeted therapies (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 21, 2019 Category: Radiology Source Type: news
Woman who underwent chemotherapy for rare form of cancer during pregnancy kisses her 'miracle' baby
Jade Devis, 36, of Rancho Cucamonga, California, was diagnosed with stage 2 triple-negative breast cancer, a rare form of the disease, just a few months after learning that she was pregnant. (Source: the Mail online | Health)
Source: the Mail online | Health - October 28, 2019 Category: Consumer Health News Source Type: news
